Metabolites | Free Full-Text | Mucosal Metabolomic Profiling and Pathway Analysis Reveal the Metabolic Signature of Ulcerative Colitis | HTML
![PDF] Correlation of endoscopic disease severity with pediatric ulcerative colitis activity index score in children and young adults with ulcerative colitis | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/3487ab107b3dfb52cb7dc2f7872fa75c27538395/5-Table4-1.png "PDF] Correlation of endoscopic disease severity with pediatric ulcerative colitis activity index score in children and young adults with ulcerative colitis | Semantic Scholar")
PDF] Correlation of endoscopic disease severity with pediatric ulcerative colitis activity index score in children and young adults with ulcerative colitis | Semantic Scholar
Diagnosis of acute severe colitis
Efficacy and Safety of SPD476 in Maintaining Remission in Patients With Ulcerative Colitis Purpose
WO2014096873A1 - Biomarkers in inflammatory bowel disease - Google Patents
Disease activity index (Schroeder and colleagues 14 ) | Download Table
Use of the ulcerative colitis endoscopic index of severity and Mayo endoscopic score for predicting the therapeutic effect of mesalazine in patients with ulcerative colitis - ScienceDirect
Remission endpoints in ulcerative colitis: A systematic review
CDAI calculator (Crohn's Disease Activity Index)
Inflammatory Bowel Disease | Clinical Gate
WO2014096873A1 - Biomarkers in inflammatory bowel disease - Google Patents
Remission endpoints in ulcerative colitis: A systematic review
Defining endoscopic response and remission in ulcerative colitis clinical trials: an international consensus - Vuitton - 2017 - Alimentary Pharmacology & Therapeutics - Wiley Online Library
Inflammatory Bowel Disease | Clinical Gate
Guidelines for the management of ulcerative colitis in the adult population (update)
Cells | Free Full-Text | A Phase 2a, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial of IBD98-M Delayed-Release Capsules to Induce Remission in Patients with Active and Mild to Moderate Ulcerative Colitis
Modifi ed Mayo Disease Activity Index (MMDAI) a | Download Table
Combined oral and enema treatment with Pentasa (mesalazine) is superior to oral therapy alone in patients with extensive mild/moderate active ulcerative colitis: a randomised, double blind, placebo controlled study | Gut
Scores on Harvey Bradshaw Index (HB) and Ulcerative Colitis Disease... | Download Scientific Diagram
Effectiveness of budesonide MMX (Cortiment) for the treatment of mild-to-moderate active ulcerative colitis: study protocol for a prospective multicentre observational cohort study | BMJ Open Gastroenterology
The Efficacy of the Consumption of n-3 Polyunsaturated Fatty Acids for the Maintenance of Remission in Patients with Inflammatory Bowel Disease
Modifi ed Mayo Disease Activity Index (MMDAI) a | Download Table
Systematic review with meta‐analysis: endoscopic and histologic placebo rates in induction and maintenance trials of ulcerative colitis - Ma - 2018 - Alimentary Pharmacology & Therapeutics - Wiley Online Library
Comparison of the Ulcerative Colitis Disease Activity Index between the... | Download Table
UC-Disease Activity Index | Download Table
Once-Daily Budesonide MMX® Extended-Release Tablets Induce Remission in Patients With Mild to Moderate Ulcerative Colitis: Results From the CORE I Study - Gastroenterology
